PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets

被引：3
作者：
Marques, Miriam [1 ]
Real, Francisco X. [1 ,2 ]
机构：
[1] Spanish Natl Canc Res Ctr, Canc Cell Biol Programme, Epithelial Carcinogenesis Grp, Melchor Fernandez Almagro 3, Madrid 28029, Spain
[2] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain
来源：
EUROPEAN UROLOGY | 2017年 / 71卷 / 06期
关键词：
MUTATIONS; FGFR3;
D O I：
10.1016/j.eururo.2017.01.049
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：863 / 865
页数：3
相关论文
共 50 条
  • [31] Targeting Fibroblast Growth Factor Receptor Pathway: Precision Medicine for Biliary Cancer and Beyond
    Uson Jr, Pedro Luiz Serrano
    Borad, Mitesh J.
    SEMINARS IN LIVER DISEASE, 2023, 43 (02) : 218 - 225
  • [32] Fibroblast Growth Factor Receptor Inhibition Synergizes With Paclitaxel and Doxorubicin in Endometrial Cancer Cells
    Byron, Sara A.
    Loch, David C.
    Pollock, Pamela M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1517 - 1526
  • [33] Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets
    Pietzak, Eugene J.
    Bagrodia, Aditya
    Cha, Eugene K.
    Drill, Esther N.
    Iyer, Gopa
    Isharwal, Sumit
    Ostrovnaya, Irina
    Baez, Priscilla
    Li, Qiang
    Berger, Michael F.
    Zehir, Ahmet
    Schultz, Nikolaus
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    Dalbagni, Guido
    Al-Ahmadie, Hikmat
    Solit, David B.
    Bochner, Bernard H.
    EUROPEAN UROLOGY, 2017, 72 (06) : 952 - 959
  • [34] Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells
    Marshall, Marianne E.
    Hinz, Trista K.
    Kono, Scott A.
    Singleton, Katherine R.
    Bichon, Brady
    Ware, Kathryn E.
    Marek, Lindsay
    Frederick, Barbara A.
    Raben, David
    Heasley, Lynn E.
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5016 - 5025
  • [35] The role of fibroblast growth factors and their receptors in gliomas: the mutations involved
    Georgiou, Vasiliki
    Gkretsi, Vasiliki
    REVIEWS IN THE NEUROSCIENCES, 2019, 30 (05) : 543 - 554
  • [36] An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
    Kolli, Vidyalatha
    Paul, Subhankar
    Sarkar, Nandini
    CURRENT PROTEOMICS, 2015, 12 (03) : 144 - 151
  • [37] Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
    Dieci, Maria Vittoria
    Arnedos, Monica
    Andre, Fabrice
    Soria, Jean Charles
    CANCER DISCOVERY, 2013, 3 (03) : 264 - 279
  • [38] Fibroblast Growth Factor Receptor Signaling Crosstalk in Skeletogenesis
    Miraoui, Hichem
    Marie, Pierre J.
    SCIENCE SIGNALING, 2010, 3 (146)
  • [39] Molecular signaling in pathogenesis of craniosynostosis: the role of fibroblast growth factor and transforming growth factor-β
    Chim, Harvey
    Manjila, Sunil
    Cohen, Alan R.
    Gosain, Arun K.
    NEUROSURGICAL FOCUS, 2011, 31 (02)
  • [40] Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer
    Miyake, Makito
    Sugano, Kokichi
    Sugino, Hitomi
    Imai, Kazuho
    Matsumoto, Eri
    Maeda, Koshi
    Fukuzono, Shinich
    Ichikawa, Hiroki
    Kawashima, Kiyotaka
    Hirabayashi, Kaoru
    Kodama, Tetsuro
    Fujimoto, Hiroyuki
    Kakizoe, Tadao
    Kanai, Yae
    Fujimoto, Kiyohide
    Hirao, Yoshihiko
    CANCER SCIENCE, 2010, 101 (01) : 250 - 258
12345